By Business/Source
Currency:EUR
2025/FY
Stock NameRevenueRatio
Biopharmaceuticals7.74B100.00%
By Country/Region
Currency:EUR
2025/FY
Stock NameRevenueRatio
United States4.61B59.55%
Other countries592M7.65%
Other444M5.74%
Europe - other441M5.70%
Germany425M5.49%
Japan315M4.07%
Spain271M3.50%
Other revenue265M3.42%
France (Including French Territories)195M2.52%
Italy183M2.36%
View all